Piotr Rutkowski

Researcher Next ID · RN-002621

Researcher · Medicine

Padua, Italy

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Sarcoma Diagnosis and Treatment

Cutaneous Melanoma Detection and Management

Melanoma and MAPK Pathways

Gastrointestinal Tumor Research and Treatment

Cancer Immunotherapy and Biomarkers

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910836
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709684
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1412082
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60868-x

No projects listed.